Strategic Information
Data helps to focus and guide public health interventions, both globally and in countries, to improve the delivery of health services to all people. The WHO Department of Global HIV, Hepatitis and Sexually Transmitted Infections (HHS) programme focuses on people-centred data to improve prevention, testing and treatment services.
WHO provides global reports; collects and validates data with partners through the Global AIDS Monitoring mechanism; and develops guidelines for strategic information, case surveillance, patient monitoring, digital health and data use. The strategic information team works with regions and countries to strengthen monitoring and evaluation systems, which are a key building block in country health systems.
Latest policy guidance
Digital adaptation kit for HIV, second edition
Policy briefs
Measuring HIV prevention programmes against health outcomes (such as individuals remaining HIV-negative or new HIV infections) can be challenging. This...
Policy brief on integrating and strengthening monitoring of differentiated ART service delivery
These recommendations include approaches for differentiated service delivery (DSD) of antiretroviral therapy (ART) that are less intensive and provide...
Policy brief on digital health data
The new Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact 1 aim to help countries improve how...
Sexually transmitted infections (STIs), viral hepatitis and cervical cancer are important concerns for any country implementing HIV programmes because...
Programmatic data routinely collected at service delivery sites can play an important role in the measuring and monitoring of HIV incidence and prevalence,...
Enhancing the monitoring of HIV testing and treatment
Person-centred monitoring generates individual level data to monitor the health status of people living with HIV over time and ensure the quality and continuity...
Technical documents
WHO Data quality assessment of national and partner monitoring data and system implementation tool –...
This technical brief summarizes key updates to the 2018 Data quality assessment of national and partner HIV treatment and patient monitoring data and systems...
Module for assessing and strengthening the quality of viral load testing data within HIV programmes andpatient...
This technical update of the 2020 viral load data quality module provides further guidance on the recommended data quality assurance activities, updated...
Using recency assays for HIV surveillance: 2022 technical guidance
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency...
Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021
This report provides accountability for the 3 Global Health Sector Strategies (2016-2021) on HIV, Viral Hepatitis and the STIs. The report assesses the...
Module for assessing and strengthening the quality of viral load testing data within HIV programmes and...
The overarching goal of this module is to support the assessment of data quality (DQ), strengthen data and patient monitoring systems and support data...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV...
In April 2020, new directions in global guidance for HIV strategic information and treatment monitoring were updated. This technical update outlines the...
Considerations for developing a monitoring and evaluation framework for viral load testing
The WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommend viral load as the preferred monitoring...
Data quality assessment of national and partner HIV treatment and patient monitoring data and systems...
In the past decade, national programmes and donor-funded projects have made great progress in reaching people living with HIV with life-saving treatment...
This guide supports the use of data to identify and fill gaps in services in order to improve HIV and health programmes. Following from the Consolidated...
Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months...
The guidelines fill a gap in providing tools for surveying HIV prevalence in key populations, and the included questionnaires may also inform general population...